A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Stephen Salloway, Paul Aisen(University of Pittsburgh), Serge Gauthier(McGill University), Clifford R. Jack(Mayo Clinic), Richard J. Perrin(Washington University in St. Louis), Sarah Berman(University of Pittsburgh Medical Center), Anne M. Fagan(Washington University in St. Louis), David Wallon(Centre Hospitalier Universitaire de Rouen), Ivonne Z. Jiménez‐Velázquez(University of Puerto Rico System), Anna Santacruz(Washington University in St. Louis), Carlos Cruchaga(Washington University in St. Louis), Kelley A. Coalier(Washington University in St. Louis), William S. Brooks(UNSW Sydney), Raquel Sánchez‐Valle(Universitat de Barcelona), Colin L. Masters(Mental Health Research Institute), Florence Pasquier, Maïté Formaglio(Hospices Civils de Lyon), Ging‐Yuek Robin Hsiung(University of British Columbia), Jason Hassenstab(Washington University in St. Louis), Suman Jayadev(University of Washington), John C. Morris(Mayo Clinic), Roger Clarnette(The University of Western Australia), Eric McDade(University of Pittsburgh), Catherine J. Mummery(University College London), Martin R. Farlow(MRC Laboratory of Molecular Biology), Ghulam M. Surti(Brown University), Douglas Galasko(University of California San Diego), Guoqiao Wang(Washington University in St. Louis), Jared R. Brosch(Indiana University School of Medicine), Didier Hannequin(Hôpital Charles-Nicolle), James J. Lah(German Center for Neurodegenerative Diseases), Christopher H. van Dyck(University Memory and Aging Center), Erik D. Roberson(University of Alabama at Birmingham), Robert A. Koeppe(University of Utah), Mario Masellis(Sunnybrook Health Science Centre), Peter J. Snyder(University of Washington), Andrew J. Aschenbrenner(Washington University in St. Louis), Alison Goate(Icahn School of Medicine at Mount Sinai), Brian A. Gordon(Washington University in St. Louis), Jorge J. Llibre‐Guerra(Washington University in St. Louis), Yan Li(Washington University in St. Louis), Susan L. Mills(Washington University in St. Louis), Jérémie Pariente(National Hospital for Neurology and Neurosurgery), Bruno Dubois(Sorbonne Université), B. Joy Snider(Washington University in St. Louis), David B. Clifford(Washington University in St. Louis), Janice M. Hitchcock(Dartmouth–Hitchcock Medical Center), Tammie L.S. Benzinger(Washington University in St. Louis), Chengjie Xiong(Ludwig-Maximilians-Universität München), Lawrence S. Honig(Columbia University)
Cited by 364
Related Papers
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k